{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:58:41Z","timestamp":1790812721449,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Feasibility of exercise in patients with metastatic cancer is still a challenge. This study aimed to determine the feasibility and preliminary efficacy of an exercise intervention based on a patient-preferred delivery mode in patients affected by metastatic cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>Forty-four patients with a confirmed diagnosis of metastatic cancer were recruited in a 3-month exercise program. Whereas the exercise program consisted of aerobic and resistance activities performed twice a week, the participants may choose the mode of delivery: home based, personal training, or group based. The primary endpoint was the feasibility, defined by recruitment rate, attendance, adherence, dropout rate, tolerability (comparing the session RPE with the target RPE), and safety (using the Common Terminology Criteria for Adverse Events, version 5.0). Secondary endpoints included cardiorespiratory fitness (six minutes walking test), muscle strength (handgrip strength test and isometric leg press test), flexibility (the back scratch and chair sit and reach tests), anthropometric parameters (body mass index and waist-hip ratio), quality of life (EORTC QLQ C-30 questionnaire), and amount of physical exercise (Godin\u2019s Shepard Leisure Time Exercise Questionnaire). Descriptive statistics, Student t test, and Wilcoxon signed rank test were used to analyze data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study recruitment rate was 81%. Out of 44 recruited patients, 28 chose the personal training program, 16 chose the home-based program, and none chose the group-based program. Nine dropouts occurred (20%), 6 in the personal training program, and 3 in the home-based intervention. The median attendance rate was 92%, adherence was 88%, tolerability was 100%, and 9 nonsevere adverse events were registered during the exercise sessions. An increase in cardiorespiratory fitness (P\u2005&amp;lt;\u2005.001) and flexibility (P\u2005=\u2005.011 for chair sit and reach; P\u2005=\u2005.040 for back scratch) was observed at the end of the intervention, while no changes in anthropometric values and muscle strength were detected. Different quality-of-life domains were improved following the intervention, including physical (P\u2005=\u2005.002), emotional (P\u2005&amp;lt;\u2005.001), and role functioning (P\u2005=\u2005.018), fatigue (P\u2005=\u2005.030), and appetite loss (P\u2005=\u2005.005).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A 3-month exercise program based on a patient-preferred delivery mode is feasible in patients with metastatic cancer and may improve physical function and quality of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial Registration<\/jats:title>\n                  <jats:p>NCT04226508<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyae002","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T17:52:10Z","timestamp":1704995530000},"page":"e828-e836","source":"Crossref","is-referenced-by-count":15,"title":["A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2439-4799","authenticated-orcid":false,"given":"Alice","family":"Avancini","sequence":"first","affiliation":[{"name":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Borsati","sequence":"additional","affiliation":[{"name":"Biomedical, Clinical and Experimental Sciences, Department of Medicine, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Baldo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ciurnelli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Trestini","sequence":"additional","affiliation":[{"name":"Dietetic Service, Medical Direction, Azienda Ospedaliera Universitaria Integrata di Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tregnago","sequence":"additional","affiliation":[{"name":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Belluomini","sequence":"additional","affiliation":[{"name":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sposito","sequence":"additional","affiliation":[{"name":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Insolda","sequence":"additional","affiliation":[{"name":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Auriemma","sequence":"additional","affiliation":[{"name":"Section of Oncology, University of Verona Hospital Trust (AOUI) Verona , Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fiorio","sequence":"additional","affiliation":[{"name":"Section of Oncology, University of Verona Hospital Trust (AOUI) Verona , Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Piacentini","sequence":"additional","affiliation":[{"name":"Section of Oncology, University of Verona Hospital Trust (AOUI) Verona , Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Schena","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-5237","authenticated-orcid":false,"given":"Michele","family":"Milella","sequence":"additional","affiliation":[{"name":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2229-4874","authenticated-orcid":false,"given":"Sara","family":"Pilotto","sequence":"additional","affiliation":[{"name":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"2024060305544836900_CIT0001","first-page":"5574","article-title":"Are 90% of deaths from cancer caused by metastases","volume-title":"Cancer Med.","author":"Dillekas","year":"2019"},{"key":"2024060305544836900_CIT0002","first-page":"1476","article-title":"Estimation of the number of individuals living with metastatic cancer in the United States","volume-title":"J Natl Cancer Inst.","author":"Gallicchio","year":"2022"},{"key":"2024060305544836900_CIT0003","first-page":"76","article-title":"Future trends in incidence and long-term survival of metastatic cancer in the United States","volume-title":"Commun Med (Lond).","author":"Hudock","year":"2023"},{"key":"2024060305544836900_CIT0004","first-page":"5889","article-title":"Patient-reported symptom burden and supportive care needs at cancer diagnosis: a retrospective cohort study","volume-title":"Support Care Cancer.","author":"Cuthbert","year":"2020"},{"key":"2024060305544836900_CIT0005","first-page":"1423","article-title":"Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer","volume-title":"Support Care Cancer.","author":"Batra","year":"2021"},{"key":"2024060305544836900_CIT0006","first-page":"811","article-title":"A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trial","volume-title":"J Pain Symptom Manage.","author":"Cheville","year":"2013"},{"key":"2024060305544836900_CIT0007","first-page":"328","article-title":"Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases","volume-title":"Prostate Cancer Prostatic Dis.","author":"Cormie","year":"2013"},{"key":"2024060305544836900_CIT0008","first-page":"393","article-title":"Exercise preserves physical function in prostate cancer patients with bone metastases","volume-title":"Med Sci Sports Exerc.","author":"Galvao","year":"2018"},{"key":"2024060305544836900_CIT0009","first-page":"302","article-title":"Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer","volume-title":"Prostate Cancer Prostatic Dis.","author":"Hanson","year":"2023"},{"key":"2024060305544836900_CIT0010","first-page":"1649","article-title":"Physical exercise for cancer patients with advanced disease: a randomized controlled trial","volume-title":"Oncologist.","author":"Oldervoll","year":"2011"},{"key":"2024060305544836900_CIT0011","first-page":"67","article-title":"Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial","volume-title":"BMC Cancer.","author":"Rief","year":"2014"},{"key":"2024060305544836900_CIT0012","first-page":"615","article-title":"Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial","volume-title":"Support Care Cancer.","author":"Zimmer","year":"2018"},{"key":"2024060305544836900_CIT0013","first-page":"2552","article-title":"Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: a randomized controlled trial","volume-title":"Cancer.","author":"Scott","year":"2018"},{"key":"2024060305544836900_CIT0014","first-page":"1666","article-title":"Safety, feasibility, and effectiveness of implementing supervised exercise into the clinical care of individuals with advanced cancer","volume-title":"Clin Rehabil.","author":"Gil Herrero","year":"2022"},{"key":"2024060305544836900_CIT0015","first-page":"404","article-title":"Exercise interventions in metastatic cancer disease: a literature review and a brief discussion on current and future perspectives","volume-title":"BMJ Support Palliat Care.","author":"Wilk","year":"2020"},{"key":"2024060305544836900_CIT0016","first-page":"6078","article-title":"Exercise and bone health in cancer: enemy or ally","volume-title":"Cancers (Basel).","author":"Avancini","year":"2022"},{"key":"2024060305544836900_CIT0017","first-page":"e555","article-title":"Physical activity and exercise in lung cancer care: will promises be fulfilled","volume-title":"Oncologist.","author":"Avancini","year":"2020"},{"key":"2024060305544836900_CIT0018","first-page":"1","article-title":"Factors influencing physical activity in cancer patients during oncological treatments: a qualitative study","volume-title":"Integr Cancer Ther.","author":"Avancini","year":"2020"},{"key":"2024060305544836900_CIT0019","first-page":"5351","article-title":"Exercise levels and preferences in cancer patients: a cross-sectional study","volume-title":"Int J Environ Res Public Health.","author":"Avancini","year":"2020"},{"key":"2024060305544836900_CIT0020","first-page":"4134","article-title":"Precision oncology framework for investigation of exercise as treatment for cancer","volume-title":"J Clin Oncol.","author":"Jones","year":"2015"},{"key":"2024060305544836900_CIT0021","first-page":"i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume-title":"BMJ.","author":"Eldridge","year":"2016"},{"key":"2024060305544836900_CIT0022","first-page":"1123","article-title":"Efficacy and feasibility of presurgical exercise in bladder cancer patients scheduled for open radical cystectomy","volume-title":"Med Sci Sports Exerc.","author":"Taaffe","year":"2023"},{"key":"2024060305544836900_CIT0023","first-page":"14694","article-title":"Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy","volume-title":"Cancer Med.","author":"Crosby","year":"2023"},{"key":"2024060305544836900_CIT0024","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE)","author":"Institute, NC","year":"2022"},{"key":"2024060305544836900_CIT0025","first-page":"124","article-title":"Exercise interventions for individuals with advanced cancer: a systematic review","volume-title":"Prev Med.","author":"Dittus","year":"2017"},{"key":"2024060305544836900_CIT0026","first-page":"3031","article-title":"Safety and feasibility of exercise interventions in patients with advanced cancer: a systematic review","volume-title":"Support Care Cancer.","author":"Heywood","year":"2017"},{"issue":"1","key":"2024060305544836900_CIT0027","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"Laboratories, ACoPSfCPF","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"2024060305544836900_CIT0028","first-page":"120","article-title":"Handgrip strength testing: a review of the literature","volume-title":"Aust Occup Ther J","author":"Innes","year":"1999"},{"key":"2024060305544836900_CIT0029","first-page":"2044","article-title":"A vertical jump force test for assessing bilateral strength asymmetry in athletes","volume-title":"Med Sci Sports Exerc.","author":"Impellizzeri","year":"2007"},{"key":"2024060305544836900_CIT0030","first-page":"255","article-title":"Development and validation of criterion-referenced clinically relevant fitness standards for maintaining physical independence in later years","volume-title":"Gerontologist.","author":"Rikli","year":"2013"},{"key":"2024060305544836900_CIT0031","volume-title":"The use and interpretation of anthropometry. Report of a World Health Organization Expert Comitee","author":"Organization, WH","year":"1995"},{"key":"2024060305544836900_CIT0032","first-page":"365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume-title":"J Natl Cancer Inst.","author":"Aaronson","year":"1993"},{"key":"2024060305544836900_CIT0033","first-page":"60","article-title":"The use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic review","volume-title":"BMC Med Res Methodol.","author":"Amireault","year":"2015"},{"key":"2024060305544836900_CIT0034","first-page":"106","article-title":"The feasibility and impact of a presurgical exercise intervention program (prehabilitation) for patients undergoing cystectomy for bladder cancer","volume-title":"Urology.","author":"Kaye","year":"2020"},{"key":"2024060305544836900_CIT0035","first-page":"4478","article-title":"A systematic review of the safety, feasibility and benefits of exercise for patients with advanced cancer","volume-title":"Cancers (Basel).","author":"De Lazzari","year":"2021"},{"key":"2024060305544836900_CIT0036","first-page":"e013719","article-title":"CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer","volume-title":"BMJ Open.","author":"Tsianakas","year":"2017"},{"key":"2024060305544836900_CIT0037","first-page":"103726","article-title":"Effect of exercise on functional capacity in patients with advanced cancer: a meta-analysis of randomized controlled trials","volume-title":"Crit Rev Oncol Hematol.","author":"Avancini","year":"2022"},{"key":"2024060305544836900_CIT0038","first-page":"67","article-title":"Effects of a 12-week multimodal exercise intervention among older patients with advanced cancer: results from a randomized controlled trial","volume-title":"Oncologist.","author":"Mikkelsen","year":"2022"},{"key":"2024060305544836900_CIT0039","first-page":"315","article-title":"Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer","volume-title":"Eur Heart J Qual Care Clin Outcomes.","author":"Groarke","year":"2020"},{"key":"2024060305544836900_CIT0040","first-page":"14005","article-title":"Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer","volume-title":"Sci Rep.","author":"Kirkham","year":"2021"},{"key":"2024060305544836900_CIT0041","first-page":"2375","article-title":"Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable","volume-title":"Med Sci Sports Exerc.","author":"Campbell","year":"2019"},{"key":"2024060305544836900_CIT0042","first-page":"713","article-title":"Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment","volume-title":"Ann Oncol.","author":"Fabi","year":"2020"},{"key":"2024060305544836900_CIT0043","first-page":"102","article-title":"Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008","volume-title":"Health Qual Life Outcomes.","author":"Montazeri","year":"2009"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyae002\/58038369\/oyae002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyae002\/58038369\/oyae002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:38:47Z","timestamp":1717425527000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/6\/e828\/7516951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,1,11]]},"published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyae002","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6,1]]},"published":{"date-parts":[[2024,1,11]]}}}